Doctor profile · Federal record
Dr. Brett Buchmiller, M.D.
Allergy & Immunology Physician (CMS: Allergy/Immunology) · Allergy & Immunology Physician · Internal Medicine Physician · Pediatrics Physician · Marysville, WA
- NPI 1558397265
- Accepts Medicare
- 29 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
2901 174Th St Ne
Marysville, WA 982714743
(360) 454-1912
fax (360) 454-1985 - Additional location
-
3901 Hoyt Ave
Everett, WA 982014918
(425) 339-5412 - Mailing address
-
Po Box 5127
Everett, WA 982065127
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- April 5, 2023
- Year of graduation
- 1997 — 29 yrs since
- Specialty taxonomy
- 207K00000X — NUCC code
- State licenses (2)
- Washington #MD60282454 · Texas #L0055
- Medicaid (2)
- WA #2017491 · TX #144365701
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1558397265. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
22,686
Distinct HCPCS
10
Medicare allowed
$921,137
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1561 |
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 7,090 | 15 | $48 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 6,850 | 16 | $42 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 6,470 | 50 | $33 | |
95004 |
Test for allergy using allergenic extract | 819 | 22 | $4 | |
J3489 |
Injection, zoledronic acid, 1 mg | 315 | 63 | $8 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 286 | 107 | $66 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 193 | 71 | $135 | |
95117 |
Professional service for multiple injections of allergen | 134 | 22 | $12 | |
96366 |
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 109 | 13 | $21 | |
95115 |
Professional service for single injection of allergen | 85 | 14 | $10 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 957. This provider delivers 24× the peer median.Medicare Part D · 2023
Top prescriptions
Total claims
620
Patients
136
Total drug cost
$544,487
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Montelukast Sodium | Generic | 129 | 33 | $1,587 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 94 | 41 | $2,561 |
| Nucala (Mepolizumab) | Brand | 61 | 0 | $421,420 |
| Azelastine Hcl | Generic | 58 | 25 | $2,527 |
| Advair Hfa (Fluticasone Propion/Salmeterol) | Brand | 49 | 11 | $36,744 |
| Dulera (Mometasone/Formoterol) | Brand | 27 | 0 | $14,040 |
| Prednisone | Generic | 27 | 11 | $173 |
| Fluticasone-Salmeterol (Fluticasone Propion/Salmeterol) | Brand | 26 | 0 | $7,941 |
| Famotidine | Generic | 23 | 0 | $206 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 22 | 0 | $13,227 |
Frequently asked questions
What is Dr. Brett Buchmiller's medical specialty?
Dr. Brett Buchmiller practices Allergy & Immunology Physician in Marysville, WA.
Where does Dr. Brett Buchmiller practice?
Dr. Brett Buchmiller practices at 2901 174Th St Ne, Marysville, WA 982714743. Office phone: 3604541912.
What is Dr. Brett Buchmiller's NPI?
Dr. Brett Buchmiller's National Provider Identifier (NPI) is 1558397265, issued by NPPES.
Does Dr. Brett Buchmiller accept Medicare assignment?
Yes. Dr. Brett Buchmiller accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Brett Buchmiller commonly perform?
Top Medicare-reported procedures in 2023: Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg (HCPCS J1561); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745). Source: CMS Medicare Physician & Other Practitioners file.